These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1426567)

  • 1. Inhibition of chymotrypsin by phenyl N-phenyl-phosphoramidochloridate.
    Parkin J; Tomkinson NP; Virden R
    Biochem Soc Trans; 1992 Aug; 20(3):283S. PubMed ID: 1426567
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel diphenyl esters of peptidyl alpha-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin.
    Pietrusewicz E; Sieńczyk M; Oleksyszyn J
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1229-36. PubMed ID: 19912056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of chymotrypsin by alkyl phosphonates: a quantitative structure-activity analysis.
    Silipo C; Hansch C; Grieco C; Vittoria A
    Arch Biochem Biophys; 1979 May; 194(2):552-7. PubMed ID: 443820
    [No Abstract]   [Full Text] [Related]  

  • 4. Diastereomeric phosphonate ester adducts of chymotrypsin: 31P-NMR measurements.
    Kovach IM; McKay L; Vander Velde D
    Chirality; 1993; 5(3):143-9. PubMed ID: 8338724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible inhibition of serine proteases by peptidyl derivatives of alpha-aminoalkylphosphonate diphenyl esters.
    Oleksyszyn J; Powers JC
    Biochem Biophys Res Commun; 1989 May; 161(1):143-9. PubMed ID: 2730652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibitory conformation of dipeptides for chymotrypsin.
    Shimohigashi Y; Ogawa T; Kodama H; Sakamoto H; Yoshitomi H; Waki M; Ohno M
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1460-6. PubMed ID: 2306257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical events in delayed neurotoxicity: is aging of chymotrypsin inhibited by saligenin cyclic phosphates a model for aging of neurotoxic esterase?
    Johnson MK; Clothier B
    Toxicol Lett; 1980 Jan; 5(1):95-8. PubMed ID: 7376205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parabolic hydrophobic inhibition of alpha-chymotrypsin.
    Smith BN; Hansch C; Poindexter TP
    Physiol Chem Phys; 1974; 6(4):323-31. PubMed ID: 4457934
    [No Abstract]   [Full Text] [Related]  

  • 9. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
    Oleksyszyn J; Powers JC
    Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective and reversible inhibition of trypsin and alpha-chymotrypsin by phosphonate esters.
    Zhao Q; Kovach IM; Bencsura A; Papathanassiu A
    Biochemistry; 1994 Jul; 33(26):8128-38. PubMed ID: 8025118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the catalytic properties of alpha-chymotrypsin by chemical modification at Tyr 146.
    Gorecki M; Wilchek M; Blumberg S
    Biochim Biophys Acta; 1978 Jul; 535(1):90-9. PubMed ID: 667120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urea denaturation of active-site spin-labeled -chymotrypsin.
    Berliner LJ
    Biochemistry; 1972 Jul; 11(15):2921-4. PubMed ID: 4339473
    [No Abstract]   [Full Text] [Related]  

  • 13. The binding of boronic acids to chymotrypsin.
    Rawn JD; Lienhard GE
    Biochemistry; 1974 Jul; 13(15):3124-30. PubMed ID: 4858346
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure and activity of two photoreversible cinnamates bound to chymotrypsin.
    Stoddard BL; Bruhnke J; Porter N; Ringe D; Petsko GA
    Biochemistry; 1990 May; 29(20):4871-9. PubMed ID: 2364065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of gamma-chymotrypsin in complex with 7-hydroxycoumarin.
    Ghani U; Ng KK; Atta-ur-Rahman ; Choudhary MI; Ullah N; James MN
    J Mol Biol; 2001 Nov; 314(3):519-25. PubMed ID: 11846564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chymotrypsin inhibitory conformation of dipeptides constructed by side chain-side chain hydrophobic interactions.
    Sakamoto H; Shimohigashi Y; Maeda I; Nose T; Nakashima K; Nakamura I; Ogawa T; Kawano K; Ohno M
    J Mol Recognit; 1993 Jun; 6(2):95-100. PubMed ID: 8305253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aged and non-aged pyrenebutyl-containing organophosphoryl conjugates of chymotrypsin. Preparation and comparison by 31P-NMR spectroscopy.
    Grunwald J; Segall Y; Shirin E; Waysbort D; Steinberg N; Silman I; Ashani Y
    Biochem Pharmacol; 1989 Oct; 38(19):3157-68. PubMed ID: 2818617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants of the half-life and cleavage site preference in the autolytic inactivation of chymotrypsin.
    Bódi A; Kaslik G; Venekei I; Gráf L
    Eur J Biochem; 2001 Dec; 268(23):6238-46. PubMed ID: 11733020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conformational change in the benzeneboronic acid-alpha-chymotrypsin complex. Evidence for a conformational change in a tetrahedral adduct of alpha-chymotrypsin.
    Hanai K
    J Biochem; 1977 May; 81(5):1273-83. PubMed ID: 197063
    [No Abstract]   [Full Text] [Related]  

  • 20. Alkynyl phosphates are potent inhibitors of serine enzyme.
    Segal D; Shalitin C; Shalitin Y; Fischer DR; Stang PJ
    FEBS Lett; 1996 Aug; 392(2):117-20. PubMed ID: 8772187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.